These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 17933687)

  • 21. Transgenic models to understand hypoxia-inducible factor function.
    Doedens A; Johnson RS
    Methods Enzymol; 2007; 435():87-105. PubMed ID: 17998050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The C1772T genetic polymorphism in human HIF-1alpha gene associates with expression of HIF-1alpha protein in breast cancer.
    Kim HO; Jo YH; Lee J; Lee SS; Yoon KS
    Oncol Rep; 2008 Nov; 20(5):1181-7. PubMed ID: 18949419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of hypoxia-inducible factor-1alpha predicts an unfavorable outcome in urothelial carcinoma of the upper urinary tract.
    Ke HL; Wei YC; Yang SF; Li CC; Wu DC; Huang CH; Wu WJ
    Int J Urol; 2008 Mar; 15(3):200-5. PubMed ID: 18304212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The human HIF (hypoxia-inducible factor)-3alpha gene is a HIF-1 target gene and may modulate hypoxic gene induction.
    Tanaka T; Wiesener M; Bernhardt W; Eckardt KU; Warnecke C
    Biochem J; 2009 Oct; 424(1):143-51. PubMed ID: 19694616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia-inducible factor 1alpha mediates anoikis resistance via suppression of alpha5 integrin.
    Rohwer N; Welzel M; Daskalow K; Pfander D; Wiedenmann B; Detjen K; Cramer T
    Cancer Res; 2008 Dec; 68(24):10113-20. PubMed ID: 19074877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dexamethasone impairs hypoxia-inducible factor-1 function.
    Wagner AE; Huck G; Stiehl DP; Jelkmann W; Hellwig-Bürgel T
    Biochem Biophys Res Commun; 2008 Jul; 372(2):336-40. PubMed ID: 18501194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of hypoxia-inducible factor-1alpha and vessel endothelial growth factor in esophageal squamous cell carcinoma and clinico-pathological significance thereof].
    Yu ZT; Zhao HF; Shang XB
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2465-9. PubMed ID: 19080625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.
    Liang X; Yang D; Hu J; Hao X; Gao J; Mao Z
    Anticancer Res; 2008; 28(3A):1659-66. PubMed ID: 18630523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective killing of hypoxia-inducible factor-1-active cells improves survival in a mouse model of invasive and metastatic pancreatic cancer.
    Kizaka-Kondoh S; Itasaka S; Zeng L; Tanaka S; Zhao T; Takahashi Y; Shibuya K; Hirota K; Semenza GL; Hiraoka M
    Clin Cancer Res; 2009 May; 15(10):3433-41. PubMed ID: 19417024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer therapeutic agents targeting hypoxia-inducible factor-1.
    Wang R; Zhou S; Li S
    Curr Med Chem; 2011; 18(21):3168-89. PubMed ID: 21671859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The HIF pathway in cancer.
    Maxwell PH
    Semin Cell Dev Biol; 2005; 16(4-5):523-30. PubMed ID: 16144689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitors of hypoxia-inducible factor-1 signaling.
    Belozerov VE; Van Meir EG
    Curr Opin Investig Drugs; 2006 Dec; 7(12):1067-76. PubMed ID: 17209524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoxia inducible factor pathway inhibitors as anticancer therapeutics.
    Burroughs SK; Kaluz S; Wang D; Wang K; Van Meir EG; Wang B
    Future Med Chem; 2013 Apr; 5(5):553-72. PubMed ID: 23573973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy.
    Semenza GL
    Trends Pharmacol Sci; 2012 Apr; 33(4):207-14. PubMed ID: 22398146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia inducible factor-1: a novel target for cancer therapy.
    Belozerov VE; Van Meir EG
    Anticancer Drugs; 2005 Oct; 16(9):901-9. PubMed ID: 16162966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of hypoxia inducible factor-1 in cell metabolism--a possible target in cancer therapy.
    Bel Aiba RS; Dimova EY; Görlach A; Kietzmann T
    Expert Opin Ther Targets; 2006 Aug; 10(4):583-99. PubMed ID: 16848694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer therapy by targeting hypoxia-inducible factor-1.
    Li Y; Ye D
    Curr Cancer Drug Targets; 2010 Nov; 10(7):782-96. PubMed ID: 20578983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting hypoxia-inducible factor 1 (HIF-1) signaling with natural products toward cancer chemotherapy.
    Ikeda H; Kakeya H
    J Antibiot (Tokyo); 2021 Oct; 74(10):687-695. PubMed ID: 34331027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The HIF-1-active microenvironment: an environmental target for cancer therapy.
    Kizaka-Kondoh S; Tanaka S; Harada H; Hiraoka M
    Adv Drug Deliv Rev; 2009 Jul; 61(7-8):623-32. PubMed ID: 19409433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIF-1 signaling in drug resistance to chemotherapy.
    Warfel NA; El-Deiry WS
    Curr Med Chem; 2014; 21(26):3021-8. PubMed ID: 24735366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.